Biogen Idec (BIIB) Tops Q2 Views; Guides FY09
Tweet Send to a Friend
Biogen Idec Inc. (Nasdaq: BIIB) reports Q2 EPS of $0.75, ex-items, 7 cents ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


